Market Overview
The global plasma-derived products market was valued at USD 29,860 million in 2024 and is projected to reach USD 51,540 million by 2031, exhibiting a compound annual growth rate (CAGR) of 8.1% during the forecast period.
Plasma-derived products are therapeutic biologics manufactured from human plasma, which contains critical proteins such as immunoglobulins, clotting factors, and albumin. These products are vital for treating life-threatening conditions including hemophilia, primary immunodeficiency disorders, and autoimmune diseases. The market is segmented into immune globulin (which held a hare in 2023), coagulation factors, albumin, and other specialized plasma proteins.
Market size
MARKET INSIGHTS
USD 29,860 million in 2024 USD 51,540 million by 2031 CAGR of 8.1%
Segment Application
Our Key Players
Takeda
CSL
Grifols
Octapharma
Kedrion
LFB Group
Biotest
https://www.24lifesciences.com/downloadsample/3367/plasma-derived-productsmarket-market
